Skip to main content
Top
Published in: Breast Cancer Research 1/2021

01-12-2021 | Breast Cancer | Correction

Correction to: High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer

Authors: Gerardo Gatti, Courtney Betts, Darío Rocha, Maribel Nicola, Verónica Grupe, Cecilia Ditada, Nicolas G. Nuñez, Emiliano Roselli, Paula Araya, Jeremías Dutto, Lucia Boffelli, Elmer Fernández, Lisa M. Coussens, Mariana Maccioni

Published in: Breast Cancer Research | Issue 1/2021

Login to get access

Excerpt

Correction to: Breast Cancer Res 23, 40 (2021)
Metadata
Title
Correction to: High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer
Authors
Gerardo Gatti
Courtney Betts
Darío Rocha
Maribel Nicola
Verónica Grupe
Cecilia Ditada
Nicolas G. Nuñez
Emiliano Roselli
Paula Araya
Jeremías Dutto
Lucia Boffelli
Elmer Fernández
Lisa M. Coussens
Mariana Maccioni
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2021
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-021-01427-6

Other articles of this Issue 1/2021

Breast Cancer Research 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine